INBX
Price
$23.33
Change
-$0.61 (-2.55%)
Updated
Aug 15 closing price
Capitalization
337.72M
89 days until earnings call
SONN
Price
$3.54
Change
-$0.22 (-5.85%)
Updated
Aug 15 closing price
Capitalization
22.18M
Interact to see
Advertisement

INBX vs SONN

Header iconINBX vs SONN Comparison
Open Charts INBX vs SONNBanner chart's image
Inhibrx Biosciences
Price$23.33
Change-$0.61 (-2.55%)
Volume$97.77K
Capitalization337.72M
Sonnet BioTherapeutics Holdings
Price$3.54
Change-$0.22 (-5.85%)
Volume$609.46K
Capitalization22.18M
INBX vs SONN Comparison Chart in %
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. SONN commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Hold and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (INBX: $23.33 vs. SONN: $3.54)
Brand notoriety: INBX and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 91% vs. SONN: 11%
Market capitalization -- INBX: $337.72M vs. SONN: $22.18M
INBX [@Biotechnology] is valued at $337.72M. SONN’s [@Biotechnology] market capitalization is $22.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 2 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 2 green, 3 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while SONN’s TA Score has 2 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 4 bearish.
  • SONN’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, INBX is a better buy in the short-term than SONN.

Price Growth

INBX (@Biotechnology) experienced а +10.78% price change this week, while SONN (@Biotechnology) price change was +9.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Reported Earning Dates

INBX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($338M) has a higher market cap than SONN($22.2M). SONN has higher P/E ratio than INBX: SONN (0.29) vs INBX (0.20). SONN YTD gains are higher at: 142.466 vs. INBX (51.494). INBX has higher annual earnings (EBITDA): 1.73B vs. SONN (-13.69M). INBX has more cash in the bank: 217M vs. SONN (2.06M). SONN has less debt than INBX: SONN (90.4K) vs INBX (107M). SONN has higher revenues than INBX: SONN (1M) vs INBX (200K).
INBXSONNINBX / SONN
Capitalization338M22.2M1,523%
EBITDA1.73B-13.69M-12,663%
Gain YTD51.494142.46636%
P/E Ratio0.200.2969%
Revenue200K1M20%
Total Cash217M2.06M10,539%
Total Debt107M90.4K118,363%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INBXSONN
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSGC0.660.01
+1.23%
SafeSpace Global Corporation
DMEHF0.15N/A
+1.11%
Desert Mountain Energy Corp.
LPPSY19.24N/A
N/A
LPP SA
KARNF4.62N/A
N/A
Kernel Holding SA
BTAFF56.21-2.23
-3.82%
British American Tobacco p.l.c.

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-2.55%
AXON - INBX
48%
Loosely correlated
+0.59%
AKESF - INBX
45%
Loosely correlated
+5.68%
COGT - INBX
44%
Loosely correlated
+1.54%
SNTI - INBX
39%
Loosely correlated
-0.65%
ACET - INBX
38%
Loosely correlated
+0.80%
More

SONN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been closely correlated with PTHS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SONN jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-5.85%
PTHS - SONN
70%
Closely correlated
+10.55%
INBX - SONN
28%
Poorly correlated
-2.55%
DWTX - SONN
27%
Poorly correlated
+0.20%
PRME - SONN
27%
Poorly correlated
-1.92%
JSPR - SONN
26%
Poorly correlated
+2.64%
More